다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

NXTC

NextCure (NXTC)

NextCure Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NXTC

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/03	05:05	GlobeNewswire Inc.	NextCure Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:NXTC	NextCure Inc
2024/04/25	05:05	GlobeNewswire Inc.	NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024	NASDAQ:NXTC	NextCure Inc
2024/04/08	20:00	GlobeNewswire Inc.	NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024	NASDAQ:NXTC	NextCure Inc
2024/04/04	20:05	GlobeNewswire Inc.	NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board	NASDAQ:NXTC	NextCure Inc
2024/04/02	20:00	GlobeNewswire Inc.	NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:NXTC	NextCure Inc
2024/03/21	21:55	GlobeNewswire Inc.	NextCure Provides Business Update and Reports Full Year 2023 Financial Results	NASDAQ:NXTC	NextCure Inc
2024/03/05	22:05	GlobeNewswire Inc.	NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances	NASDAQ:NXTC	NextCure Inc
2024/02/02	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2024/02/02	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2024/02/02	06:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2024/02/02	06:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2024/02/02	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2024/02/02	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXTC	NextCure Inc
2024/01/19	06:05	GlobeNewswire Inc.	NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders	NASDAQ:NXTC	NextCure Inc
2023/12/21	21:05	GlobeNewswire Inc.	NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury	NASDAQ:NXTC	NextCure Inc
2023/12/14	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXTC	NextCure Inc
2023/12/14	20:45	GlobeNewswire Inc.	NextCure Provides Year-End Clinical Pipeline Updates	NASDAQ:NXTC	NextCure Inc
2023/11/20	21:00	GlobeNewswire Inc.	NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference	NASDAQ:NXTC	NextCure Inc
2023/11/16	06:05	GlobeNewswire Inc.	NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML	NASDAQ:NXTC	NextCure Inc
2023/11/03	05:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NXTC	NextCure Inc
2023/11/03	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXTC	NextCure Inc
2023/11/03	05:05	GlobeNewswire Inc.	NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results	NASDAQ:NXTC	NextCure Inc
2023/10/17	21:05	GlobeNewswire Inc.	Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI)	NASDAQ:NXTC	NextCure Inc
2023/09/27	05:05	GlobeNewswire Inc.	NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease	NASDAQ:NXTC	NextCure Inc
2023/09/12	21:05	GlobeNewswire Inc.	A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC	NASDAQ:NXTC	NextCure Inc
2023/09/08	05:05	GlobeNewswire Inc.	NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen	NASDAQ:NXTC	NextCure Inc
2023/09/06	05:05	GlobeNewswire Inc.	Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease	NASDAQ:NXTC	NextCure Inc
2023/08/31	20:00	GlobeNewswire Inc.	NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:NXTC	NextCure Inc
2023/08/05	05:58	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NXTC	NextCure Inc
2023/08/05	05:30	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:NXTC	NextCure Inc

검색 관련기사 보기:NASDAQ:NXTC

1 2 3 4 5 6 7 8 9 다음 >>

United Parcel Service

BNP Paribas Issuance

G&P Acquisition

Flexpath Index Aggressiv...

reflector.finance

Vontobel Financial Produ...

NLBNPIT21JY0 20240918 5800

AGF Systematic Global Mu...

Orron Energy AB

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관